Archita Sharma

Dr. Archita Sharma

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Science Advances
Verified
Journal Article
Open access
Md. Saifur RahmanMd. Saifur Rahman
Md. Saifur Rahman
ASAhnsei Shon
Ahnsei Shon
RJRose Joseph
Rose Joseph
APAnton Pavlov
Anton Pavlov
ASAlex Stefanov
Alex Stefanov
Limei TianLimei Tian
Limei Tian
Conductive hydrogels are emerging as promising materials for electronic implants owing to their favorable mechanical and electrical properties. Poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate) (PEDOT:PSS) hydrogels are particularly attractive, but their preparation often requires toxic additives. Here, we introduced a nutritive sweetener, d -sorbitol, as a nontoxic additive to create soft and stretchable PEDOT:PSS conductive hydrogels. These hydrogels exhibit mechanical properties comparable with biological tissues, reducing adverse immune responses. The hydrogels can be patterned on elastic substrates using a simple, low-cost micromolding technique to fabricate soft and stretchable implantable devices for electrical stimulation and recording. The hydrogel electrodes show much lower electrochemical impedance and higher charge storage and injection capacity compared to platinum electrodes. In addition, the properties of hydrogels and devices remain stable after long-term storage and exposure to extreme conditions. We demonstrate the use of soft hydrogel-based electronic devices for effective electrical stimulation and high-quality electrical recordings in live animal models.

23 July 2023 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
ASArchita Sharma
Archita Sharma
DSDhavan Sharma
Dhavan Sharma
Feng ZhaoFeng Zhao
Feng Zhao

22 February 2021 in Soft Matter
Verified
Journal Article
Closed access
PDF file
ASArchita Sharma
Archita Sharma
PSPooja Sharma
Pooja Sharma
SRSangita Roy
Sangita Roy
The phenomenal advancement in regenerative medicines has led to the development of bioinspired materials to fabricate a biomimetic artificial extracellular matrix (ECM) to support cellular survival, proliferation, and differentiation. Researchers have diligently developed protein polymers consisting of functional sequences of amino acids evolved in nature. Nowadays, certain repetitive bioinspired polymers are treated as an alternative to synthetic polymers due to their unique properties like biodegradability, easy scale-up, biocompatibility, and non-covalent molecular associations which imparts tunable supramolecular architecture to these materials. In this direction, elastin has been identified as a potential scaffold that renders extensibility and elasticity to the tissues. Elastin-like polypeptides (ELPs) are artificial repetitive polymers that exhibit lower critical solution temperature (LCST) behavior in a particular environment than synthetic polymers and hence have gained extensive interest in the fabrication of stimuli-responsive biomaterials. This review discusses in detail the unique structural aspects of the elastin and its soluble precursor, tropoelastin. Furthermore, the versatility of elastin-like peptides is discussed through numerous examples that bolster the significance of elastin in the field of regenerative medicines such as wound care, cardiac tissue engineering, ocular disorders, bone tissue regeneration, etc. Finally, the review highlights the importance of exploring short elastin-mimetic peptides to recapitulate the structural and functional aspects of elastin for advanced healthcare applications.

1 December 2023 in Bioactive Materials
Verified
Journal Article
Open access
DSDhavan Sharma
Dhavan Sharma
ASArchita Sharma
Archita Sharma
LHLinghao Hu
Linghao Hu
TCTe-An Chen
Te-An Chen
SVSarah Voon
Sarah Voon
Feng ZhaoFeng Zhao
Feng Zhao
Vascularization is a key pre-requisite to engineered anatomical scale three dimensional (3-D) constructs to ensure their nutrient and oxygen supply upon implantation. Presently, engineered pre-vascularized 3-D tissues are limited to only micro-scale hydrogels, which meet neither the anatomical scale needs nor the complexity of natural extracellular matrix (ECM) environments. Anatomical scale perfusable constructs are critically needed for translational applications. To overcome this challenge, we previously developed pre-vascularized ECM sheets with long and oriented dense microvascular networks. The present study further evaluated the patency, perfusability and innate immune response toward these pre-vascularized constructs. Macrophage-co-cultured pre-vascularized constructs were evaluated in vitro to confirm micro-vessel patency and perturbations in macrophage metabolism. Subcutaneously implanted pre-vascularized constructs remained viable and formed a functional anastomosis with host vasculature within 3 days of implantation. This completely biological pre-vascularized construct holds great potential as a building block to engineer perfusable anatomical scale tissues.

10 March 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
ASArchita Sharma
Archita Sharma
DSDhavan Sharma
Dhavan Sharma
SHStaci J Horn
Staci J Horn
ZWZeyu Wen
Zeyu Wen
JOJeffrey Ock
Jeffrey Ock
Feng ZhaoFeng Zhao
Feng Zhao
Diabetic wounds present significant clinical challenges due to their multifactorial and complex pathological characteristics. Although commercially available allogenic and xenogeneic tissue-derived acellular dermal matrices have been employed in chronic wound management, their utility is constrained by limited donor availability, potential immunogenicity, mismatched biomechanical properties, and batch-to-batch variability. Consequently, these limitations often result in incomplete wound closure and inconsistent therapeutic outcomes across patient populations. To overcome these challenges, we designed a completely biological and human dermis-specific acellular interwoven extracellular matrix (iECM). To closely replicate the ECM complexity and collagen bundle architecture of native dermis, a soft lithography-based approach was employed to guide human dermal fibroblast organization, enabling subsequent ECM deposition in an interwoven pattern. Post decellularization, the iECM retained both the compositional and structural features of native dermis, with a bulk elastic modulus (4 MPa) comparable to human dermal tissue (3-18 MPa). Upon implantation in a full-thickness diabetic rat wound model, iECM significantly accelerated healing rates by 80% compared to non-structured ECM by promoting granulation tissue formation, enhancing angiogenesis, accelerating resolution of inflammation, supporting uniform collagen deposition, and enabling complete re-epithelialization. By mimicking the architectural, compositional, and mechanical properties of native dermis, the highly biomimetic iECM presents a promising strategy for diabetic wound management. STATEMENT OF SIGNIFICANCE: Chronic wounds, like diabetic wounds, are a clinical challenge due to complex pathophysiology, impaired healing mechanisms, and limited effect of numerous treatment approaches like skin substitutes and wound dressings. This research work presents a completely biological, human cell-derived acellular dermal matrix fabricated using soft lithography, to mimic the interwoven architecture and mechanical properties of native extracellular matrix. Unlike traditional dermal matrices, the bioengineered iECM exhibits biomimicry, robustness, and regenerative potential, promoting collagen organization, angiogenesis, and re-epithelialization in chronic diabetic wound healing. This work introduces a bioinspired matrix, offering a promising advancement with the potential to transform chronic wound management.

19 November 2024 in Biomimetics
Verified
Journal Article
Open access
PDF file
ASArchita Sharma
Archita Sharma
DSDhavan Sharma
Dhavan Sharma
HLHengyu Lin
Hengyu Lin
HZHong-Cai Zhou
Hong-Cai Zhou
Feng ZhaoFeng Zhao
Feng Zhao
Drug administration is commonly used to treat chronic wounds but faces challenges such as poor bioavailability, instability, and uncontrollable release. Existing drug delivery platforms are limited by chemical instability, poor functionality, complex synthesis, and toxic by-products. Presently, research efforts are focused on developing novel drug carriers to enhance drug efficacy. Guanidinium Covalent Organic Nanosheets (gCONs) offer promising alternatives due to their high porosity, surface area, loading capacity, and ability to provide controlled, sustained, and target-specific drug delivery. Herein, we successfully synthesized self-exfoliated gCONs using a Schiff base condensation reaction and embedded curcumin (CUR), a polyphenolic pleiotropic drug with antioxidant and anti-inflammatory properties, via the wet impregnation method. The BET porosimeter exhibited the filling of gCON pores with CUR. Morphological investigations revealed the formation of sheet-like structures in gCON. Culturing human dermal fibroblasts (hDFs) on gCON demonstrated cytocompatibility even at a concentration as high as 1000 µg/mL. Drug release studies demonstrated a controlled and sustained release of CUR over an extended period of 5 days, facilitated by the high loading capacity of gCON. Furthermore, the inherent antioxidant and anti-inflammatory properties of CUR were preserved after loading into the gCON, underscoring the potential of CUR-loaded gCON formulation for effective therapeutic applications. Conclusively, this study provides fundamental information relevant to the performance of gCONs as a drug delivery system and the synergistic effect of CUR and CONs addressing issues like drug bioavailability and instability.